These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360 [TBL] [Abstract][Full Text] [Related]
5. Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice. Eastwood SL; Lyon L; George L; Andrieux A; Job D; Harrison PJ J Psychopharmacol; 2007 Aug; 21(6):635-44. PubMed ID: 17050659 [TBL] [Abstract][Full Text] [Related]
6. Embryonic and postnatal development of the serotonergic raphe system and its target regions in 5-HT1A receptor deletion or overexpressing mouse mutants. Deng DR; Djalali S; Höltje M; Grosse G; Stroh T; Voigt I; Kusserow H; Theuring F; Ahnert-Hilger G; Hörtnagl H Neuroscience; 2007 Jun; 147(2):388-402. PubMed ID: 17543467 [TBL] [Abstract][Full Text] [Related]
8. Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice. Fournet V; de Lavilléon G; Schweitzer A; Giros B; Andrieux A; Martres MP J Neurochem; 2012 Dec; 123(6):982-96. PubMed ID: 23013328 [TBL] [Abstract][Full Text] [Related]
9. Hypoglutamatergic activity in the STOP knockout mouse: a potential model for chronic untreated schizophrenia. Brenner E; Sonnewald U; Schweitzer A; Andrieux A; Nehlig A J Neurosci Res; 2007 Nov; 85(15):3487-93. PubMed ID: 17304567 [TBL] [Abstract][Full Text] [Related]
10. The stop null mice model for schizophrenia displays [corrected] cognitive and social deficits partly alleviated by neuroleptics. Bégou M; Volle J; Bertrand JB; Brun P; Job D; Schweitzer A; Saoud M; D'Amato T; Andrieux A; Suaud-Chagny MF Neuroscience; 2008 Nov; 157(1):29-39. PubMed ID: 18804150 [TBL] [Abstract][Full Text] [Related]
11. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347 [TBL] [Abstract][Full Text] [Related]
12. Expression pattern of STOP lacZ reporter gene in adult and developing mouse brain. Couégnas A; Schweitzer A; Andrieux A; Ghandour MS; Boehm N J Neurosci Res; 2007 May; 85(7):1515-27. PubMed ID: 17394261 [TBL] [Abstract][Full Text] [Related]
13. Presynaptic serotonergic modulation of 5-HT and acetylcholine release in the hippocampus and the cortex of 5-HT1B-receptor knockout mice. Rutz S; Riegert C; Rothmaier AK; Buhot MC; Cassel JC; Jackisch R Brain Res Bull; 2006 Jun; 70(1):81-93. PubMed ID: 16750486 [TBL] [Abstract][Full Text] [Related]
14. Brain-specific conditional and time-specific inducible Tph2 knockout mice possess normal serotonergic gene expression in the absence of serotonin during adult life. Kriegebaum C; Song NN; Gutknecht L; Huang Y; Schmitt A; Reif A; Ding YQ; Lesch KP Neurochem Int; 2010 Nov; 57(5):512-7. PubMed ID: 20599453 [TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor expression is increased in the hippocampus of 5-HT(2C) receptor knockout mice. Hill RA; Murray SS; Halley PG; Binder MD; Martin SJ; van den Buuse M Hippocampus; 2011 Apr; 21(4):434-45. PubMed ID: 20087884 [TBL] [Abstract][Full Text] [Related]
16. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. Keck ME; Sartori SB; Welt T; Müller MB; Ohl F; Holsboer F; Landgraf R; Singewald N J Neurochem; 2005 Mar; 92(5):1170-9. PubMed ID: 15715667 [TBL] [Abstract][Full Text] [Related]
17. Cognitive impairments in the STOP null mouse model of schizophrenia. Powell KJ; Hori SE; Leslie R; Andrieux A; Schellinck H; Thorne M; Robertson GS Behav Neurosci; 2007 Oct; 121(5):826-35. PubMed ID: 17907815 [TBL] [Abstract][Full Text] [Related]
18. NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia. Merenlender-Wagner A; Pikman R; Giladi E; Andrieux A; Gozes I Peptides; 2010 Jul; 31(7):1368-73. PubMed ID: 20417241 [TBL] [Abstract][Full Text] [Related]
19. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression. Szapacs ME; Mathews TA; Tessarollo L; Ernest Lyons W; Mamounas LA; Andrews AM J Neurosci Methods; 2004 Dec; 140(1-2):81-92. PubMed ID: 15589338 [TBL] [Abstract][Full Text] [Related]